Abstract
Nerve growth factor (NGF) is widely recognized as a target-derived factor responsible for the survival and maintenance of the phenotype of specific subsets of peripheral neurons and basal forebrain cholinergic nuclei during development and maturation. Other NGF-responsive cells are now known to belong to the hemopoietic-immune system and to populations in the brain involved in neuroendocrine functions. The concentration of NGF is elevated in a number of inflammatory and autoimmune states in conjunction with increased accumulation of mast cells. Mast cells and NGF appear to be involved in neuroimmune interactions and tissue inflammation. Mast cells themselves are capable of producing and responding to NGF, suggesting that alterations in mast cell behavior may trigger maladaptive neuroimmune tissue responses, including those of an autoimmune nature. Moreover, NGF exerts a modulatory role on sensory nociceptive nerve physiology in the adult, and appears to correlate with hyperalgesic phenomena occuring in tissue inflammation. NGF can thus be viewed as a multifactorial modulator of neuroimmune-endocrine functions.
Similar content being viewed by others
References
Levi-Montalcini R. (1987) The nerve growth factor 35 years later. Science 237, 1154–1162.
Dreyfus C. F. (1989) Effects of nerve growth factor on cholinergic brain neurons. Trends Pharmacol. Sci. 10, 145–149.
Otten U., Scully J. L., Ehrhard P. B., and Gadient R. A. (1994) Neurotrophins: signals between the nervous and immune systems. Prog. Brain Res. 103, 293–305.
Horigome K., Pryor E. D., Bullock E. M., and Johnson E. M. Jr. (1993) Mediator release from mast cells by nerve growth factor. Neurotrophin specificity and receptor mediation. J. Biol. Chem. 268, 14,881–14,887.
Solomon A., Aloe L., Pe’er J., Frucht-Pery J., Bonini S., and Levi-Schaffer F. (1998) Nerve growth factor is preformed in and activates human peripheral blood eosinophils. J. Allergy Clin. Immunol. 102, 454–460.
Pincelli C., Sevignani C., Manfredini R., Grande A., Fantini F., Bracci-Laudiero L., et al. (1994) Expression and function of nerve growth factor and nerve growth factor receptor on cultured keratinocytes. J. Invest. Dermatol. 103, 13–18.
Yaar M., Eller M. S., DiBenedetto P., Reenstra W. R., Zhai S., McQuaid R., et al. (1994) The trk family of receptors mediates nerve growth factor and neurotrophin-3 effects in melanocytes. J. Clin. Invest. 94, 1550–1562.
Polak M., Scharfmann R., Seilheimer B., Eisenbarth G., Dressler D., Verma I. M., and Potter H. (1993) Nerve growth factor induces neuron-like differentiation of a insulin-secreting pancreatic beta cell line. Proc. Natl. Acad. Sci. USA 90, 5781–5785.
Meakin S. O. and Shooter E. M. (1992) The nerve growth factor family of receptors. Trends Neurosci. 15, 323–331.
Patterson J. C. and Childs G. V. (1994) Nerve growth factor in the anterior pituitary: regulation of secretion. Endocrinology 135, 1697–1704.
Thoenen H. (1995) Neurotrophins and neuronal plasticity. Science 270, 593–598.
Thoenen H. and Barde Y.-A. (1980) Physiology of the nerve growth factor. Physiol. Rev. 60, 1284–1335.
Barde Y.-A. (1989) Trophic factors and neuronal survival. Neuron 2, 1525–1534.
Hamburger V., Brunso-Bechthold J. K., and Yip J. W. (1981) Neuronal death in the spinal ganglia of the chick embyro and its reduction by nerve growth factor. J. Neurosci. 1, 60–71.
Bothwell M. (1995) Functional interactions of neurotrophins and neurotrophin receptors. Annu. Rev. Neurosci. 18, 223–253.
Oppenheim R. W. (1991) Cell death during development of the nervous system. Annu. Rev. Neurosci. 14, 451–501.
Purves D. (1988) Body and Brain. A Trophic Theory of Neural Connections. Harvard University Press, Cambridge, MA.
Barde Y.-A., Edgar D., and Thoenen H. (1982) Purification of a new neurotrophic factor from mammalian brain. EMBO J. 1, 549–553.
Leibrock J., Lottspeich F., Hohn A., Hofer M., Hengerer B., Masiakowski P., et al. (1989) Molecular cloning and expression of brain-derived neurotrophic factor. Nature 341, 149–152.
Snider W. D. (1994) Functions of the neurotrophins during development: what the knockouts are teaching us. Cell 77, 627–638.
Ibáñez C. F. (1995) Neurotrophic factors: from structure-function studies to designing effective therapeutics. TIBTECH 13, 217–227.
Hallböök F., Ibáñez C. F., and Persson H. (1991) Evolutionary studies of the nerve growth factor family reveal a novel member abundantly expressed in Xenopus ovary. Neuron 6, 845–858.
Götz R., Köster R., Winkler C., Raulf F., Lottspeich F., Schartl M., and Thoenen H. (1994) Neurotrophin-6 is a new member of the nerve growth factor family. Nature 372, 266–269.
Lai K.-O., Fu W.-Y., Ip F. C. F., and Ip N. Y. (1998) Cloning and expression of a novel neurotrophin, NT-7, from carp. Mol. Cell. Neurosci. 11, 64–76.
Barbacid M. (1994) The trk family of neurotrophin receptors. J. Neurobiol. 25, 1386–1403.
Chao M. V. (1992) Neurotrophin receptors: a window into neuronal differentiation. Neuron 9, 583–593.
Lee K.-F., Li E., Huber L. J., Landis S. C., Sharpe A. H., Chao M. V., and Jaenisch R. (1992) Targeted mutation of the gene encoding the low affinity NGF receptor p75 leads to deficits in the peripheral sensory nervous system. Cell 69, 737–749.
Davies A. M., Lee K. F., and Jaenisch R. (1993) p75-deficient trigeminal sensory neurons have an altered response to NGF but not to other neurotrophins. Neuron 11, 565–575.
Barker P. and Shooter E. (1994) Disruption of NGF binding to the low affinity neurotrophin receptor p75LNTR reduces NGF binding to TrkA on PC 12 cells. Neuron 13, 203–215.
Jing S., Tapley P., and Barbacid M. (1992) Nerve growth factor mediates signal transduction through trk homodimer receptors. Neuron 9, 1067–1079.
Dobrowsky R., Werner M., Castellino A., Chao M., and Hannun Y. (1994) Activation of the sphingomyelin cycle through the low affinity neurotrophin receptor. Science 265, 1596–1599.
Casaccia-Bonnefil P., Carter B. D., Dobrowsky R. T., and Chao M. V. (1996) Death of oligodendrocytes mediated by the interaction of nerve growth factor with its receptor p75. Nature 383, 716–719.
Otten U., Ehrhard P., and Peck R. (1989) Nerve growth factor induces growth and differentiation of human B lymphocytes. Proc. Natl. Acad. Sci. USA 86, 10,059–10,063.
Thorpe L. W. and Perez-Polo J. R. (1987) The influence of nerve growth factor on the in vitro proliferative response of rat spleen lymphocytes. J. Neurosci. Res. 18, 134–139.
Kimata H., Yoshida A., Ishioka C., Kusunoki T., Hosoi S., and Mikawa H. (1991) Nerve growth factor specifically induces human IgG4 production. Eur. J. Immunol. 21, 137–141.
Matsuda H., Coughlin M. D., Bienenstock J., and Denburg J. A. (1988) Nerve growth factor promotes human hemopoietic colony growth and differentiation. Proc. Natl. Acad. Sci. USA 85, 6508–6512.
Brodie C. and Gelfand E. W. (1992) Functional nerve growth factor receptors on human B lymphocytes: interaction with IL 2. J. Immunol. 148, 171–178.
Thorpe L. W., Werrbach-Perez K., and Perez-Polo J. R. (1987) Effects of nerve growth factor expression on interleukin-2 receptors on cultured human lymphocytes. Ann. NY Acad. Sci. USA 496, 310–311.
Gee A. P., Boyle M. D. P., Munger K. L., Lawman M. J. P., and Young M. (1983) Nerve growth factor: stimulation of polymorphonuclear leukocyte chemotaxis in vitro. Proc. Natl. Acad. Sci. USA 80, 7215–7218.
Kannan Y. H., Ushuo H., Koyama H., Okada M., Oikawa M., Yoshihara T., et al. (1991) 2.5S Nerve growth factor enhances the survival, phagocytosis, and superoxide production of murine neutrophils. Blood 77, 1320–1325.
Boyle M. D. P., Lawman M. J. P., Gee A. P., and Young M. (1985) Nerve growth factor: a chemotactic factor for polymorphonuclear leukocytes in vivo. J. Immunol. 134, 564–568.
Screpanti I., Meco D., Scarpa S., Morrone S., Frati L., Gulino A., and Modesti A. (1992) Neuromodulatory loop mediated by nerve growth factor and interleukin 6 in thymic stromal cell cultures. Proc. Natl. Acad. Sci. USA 89, 3209–3212.
Gudat F., Laubscher A., Otten U., and Pletscher A. (1981) Shape changes induced by biologically active peptides and nerve growth factor in blood platelets of rabbits. Br. J. Pharmacol. 74, 533–538.
Pearce F. L. and Thompson H. L. (1986) Some characteristics of histamine secretion from rat peritoneal mast cells stimulated with nerve growth factor. J. Physiol. 372, 379–393.
Torcia M., Bracci-Laudiero L., Lucibello M., Rubartelli A., Cozzolino F., Aloe L., and Garaci E. (1996) Nerve growth factor is an autocrine factor for memory B lymphocytes. Cell 85, 1–20.
Ehrhard P. B., Ganter U., Bauer J., and Otten U. (1993) Expression of functional trk protooncogene in human monocytes. Proc. Natl. Acad. Sci. USA 90, 5423–5427.
Ehrhard P. B., Erb P., Graumann U., and Otten U. (1993) Expression of nerve growth factor and nerve growth factor receptor tyrosine kinase Trk in activated CD4-positive T-cell clones. Proc. Natl. Acad. Sci. USA 90, 10,984–10,988.
Lambiase A., Bracci-Laudiero L., Bonini S., Bonini S., Starace G., D’Elios M. M., et al. (1997) Human CD4+ T cell clones produce and release nerve growth factor and express high-affinity nerve growth factor receptors. J. Allergy Clin. Immunol. 100, 408–414.
Santambrogio L., Benedetti M., Chao M. V., Muzaffar R., Kulig K., Gabellini N., and Hochwald G. (1994) Nerve growth factor production by lymphocytes. J. Immunol. 153, 4488–4495.
Melamed I., Kelleher C. A., Franklin R. A., Brodie C., Hempstead B., Kaplan D., and Gelfand E. W. (1996) Nerve growth signal transduction in human B lymphocytes is mediated by gp 140 trk. Eur. J. Immunol. 26, 1985–1992.
Aloe L. and Levi-Montalcini R. (1977) Mast cells increase in tissues of neonatal rats injected with nerve growth factor. Brain Res. 133, 358–366.
Böhm A., Aloe L., and Levi-Montalcini R. (1986) Nerve growth factor enhances precocious differentiation and numerical increase in mast cells in cultures of rat splenocytes. Accad. Naz. Lincei 80, 1–6.
Stead R. H., Bienenstock J., and Stanisz A. M. (1987) Neuropeptide regulation of mucosal immunity. Immunol. Rev. 100, 333–359.
Marshall J. S., Stead R. H., McSharry C., Nielsen L., and Bienenstock J. (1990) The role of mast cell degranulation products in mast cell hyperplasia. I. Mechanism of action of nerve growth factor. J. Immunol. 144, 1886–1892.
Aloe L. (1988) The effect of nerve growth factor and its antibody on mast cells in vivo. J. Neuroimmunol. 18, 1–12.
Matsuda H., Kannan Y., Ushio H., Kiso Y., Kanemoto T., Suzuki H., and Kitamura Y. (1991) Nerve growth factor induces development of connective tissue-type mast cells in vitro from murine bone marrow cells. J. Exp. Med. 174, 7–14.
Aloe L. and De Simone R. (1989) NGF primed spleen cells injected in brain of developing rats differentiate into mast cells. Int. J. Dev. Neurosci. 7, 565–573.
Richard A., McColl S. R., and Pelletier G. (1992) Interleukin-4 and nerve growth factor can act as cofactors for interleukin-3-induced histamine production in human umbilical cord blood in serum-free culture. Br. J. Haematol. 81, 6–11.
Welker P., Grabbe J., Gibbs B., Zuberbier T., and Henz B. M. (2000) Nerve growth factor-β induces mast-cell marker expression during in vitro culture of human umbilical cord blood cells. Immunology 99, 418–426.
Bruni A., Bigon E., Boarato E., Mietto L., Leon A., and Toffano G. (1982) Interaction between nerve growth factor and lysophosphatidylserine on rat peritoneal mast cells. FEBS Lett. 138, 190–192.
Sugiyama K., Suzuki Y., and Furuta H. (1985) Histamine-release induced by 75 nerve growth factor of mouse submandibular salivary glands. Arch. Oral Biol. 30, 93–95.
Tomioka M., Stead R. H., Nielsen L., Coughlin M. D., and Bienenstock J. (1988) Nerve growth factor enhances antigen and other secretagogue-induced histamine release from rat peritoneal mast cells in the absence of phosphatidylserine. J. Allergy Clin. Immunol. 82, 599–607.
Bischoff S. C. and Dahinden C. A. (1992) Effect of nerve growth factor on the release of inflammatory mediators by mature human basophils. Blood 79, 2662–2669.
Otten U., Baumann J. B., and Girard J. (1984) Nerve growth factor induces plasma extravasation in rat skin. Eur. J. Pharmacol. 106, 199–201.
Burgi B., Otten U. H., Ochensberger B., Rihs S., Heese K., Ehrhard P. B., et al. (1996) Basophil priming by neurotrophic factors. Activation through the trk receptor. J. Immunol. 157, 5582–5588.
Leon A., Buriani A., Dal Toso R., Fabris M., Romanello S., Aloe L., and Levi-Montalcini R. (1993) Mast cells synthesize, store, and release nerve growth factor. Proc. Natl. Acad. Sci. USA 91, 3739–3743.
Nilsson G., Forsberg-Nilsson K., Xiang Z., Hallböök F., Nilsson K., and Metcalfe D. D. (1997) Human mast cells express functional TrkA and are a source of nerve growth factor. Eur. J. Immunol. 27, 2295–2301.
Tam S.-Y., Tsai M., Yamaguchi M., Yano K., Butterfield J., and Galli S. J. (1997) Expression of functional TrkA receptor tyrosine kinase in the HMC-1 human mast cell line and in human mast cells. Blood 90, 1807–1820.
Skaper S. D., Pollock M., and Facci L. (2001) Rat periotoneal mast cells differentially express and release active high molecular weight neurotrophins. J. Neurochem. 77(Suppl. 1), 52.
Horigome K., Bullock E. D., and Johnson E. M. Jr. (1994) Effects of nerve growth factor on rat peritoneal mast cells. Survival promotion and immediate-early gene induction. J. Biol. Chem. 269, 2695–2702.
Kawamoto K., Okada T., Kannan Y., Ushio H., Matsumoto M., and Matsuda H. (1995) Nerve growth factor prevents apoptosis of rat peritoneal mast cells through the trk proto-oncogene receptor. Blood 86, 4638–4644.
Bullock E. D. and Johnson E. M. Jr. (1996) Nerve growth factor induces the expression of certain cytokine genes and bcl-2 in mast cells. Potential role in survival promotion. J. Biol. Chem. 271, 27,500–27,508.
Sawada J., Itakura A., Tanaka A., Furusaka T., and Matsuda H. (2000) Nerve growth factor functions as a chemoattractant for mast cells through both mitogen-activated protein kinase and phosphatidylinositol 3-kinase signaling pathways. Blood 95, 2052–2058.
Marshall J. S., Gomi K., Blennerhassett M. G., and Bienenstock J. (1999) Nerve growth factor modifies the expression of inflammatory cytokines by mast cells via a prostanoid-dependent mechanism. J. Immunol. 162, 4271–4276.
Aloe L., Skaper S. D., Leon L., and Levi-Montalcini R. (1994) Nerve growth factor and autoimmune diseases. Autoimmunity 19, 141–150.
Persson H., Ayer-Le Lievre C., Söder O., Villar M. J., Madis Mrtsis M., Olson L., et al. (1990) Expression of β-nerve growth factor receptor mRNA in Sertoli cells downregulated by testosterone. Science 247, 704–707.
Lara H. E., McDonald J. K., and Ojeda S. R. (1990) Involvement of nerve growth factor in female sexual development. Endocrinology 126, 364–375.
Spillantini M. G., Aloe L., Alleve E., De Simone R., Goedert M., and Levi-Montalcini R. (1989) Nerve growth factor mRNA and protein increase in hypothalamus in a mouse model of aggression. Proc. Natl. Acad. Sci. USA 86, 8555–8559.
Ojeda S. R., Hill D. F., and Katz K. H. (1991) The genes encoding nerve growth factor and its receptor are expressed in the developing female rat hypothalamus. Mol. Brain Res. 9, 47–55.
Lathinen T., Soinila S., and Lakshmanan J. (1989) Biological demonstration of nerve growth factor in the rat pituitary gland. Neuroscience 30, 165–170.
Missale C., Boroni F., Sigala S., Buriani A., Fabris M., Leon A., Dal Toso R., and Spano P. (1996) Nerve growth factor in the anterior pituitary: localization in mammotroph cells and cosecretion with prolactin by a dopamine-regulated mechanism. Proc. Natl. Acad. Sci. USA 93, 4240–4245.
Borrelli E., Sawchenko P. E., and Evans R. M. (1992) Pituitary hyperplasia produced by ectopic expression of nerve growth factor. Proc. Natl. Acad. Sci. USA 89, 2764–2768.
Dicou E., Lee J., and Brachet P. (1986) Synthesis of nerve growth factor mRNA and precursor protein in the throid and patathyroid glands of the rat. Proc. Natl. Acad. Sci. USA 83, 7084–7088.
Otten U., Baumann J. B., and Girard J. (1979) Stimulation of the pituitary-adrenocortical axis by nerve growth factor. Nature 282, 413–414.
Scaccianoce S., Cigliana G., Nicolai R., Muscolo L. A., Porcu A., Navarra D., et al. (1993) Hypothalamic involvement in the activation of the pituitary-adrenocortical axis by nerve growth factor. Neuroendocrinology 58, 202–209.
Luppi P., Levi-Montalcini R., Bracci-Laudiero L., Bertolini A., Arletti R., Tavernari D., et al. (1993) NGF is released into plasma during human pregnancy: an oxytocin-mediated response? NeuroReport 4, 1063–1065.
Missale C., Boroni F., Sigala S., Zanellato A., Dal Toso R., Balsari A., and Spano P. (1994) Nerve growth factor directs differentiation of the bipotential cell line GH-3 into the mammotroph phenotype. Endocrinology 135, 290–298.
Missale C., Boroni F., Losa M., Giovanelli M., Zanellato A., Dal Toso R., et al. (1993) Nerve growth factor suppresses the transforming phenotype of human prolactinoma. Proc. Natl. Acad. Sci. USA 90, 7961–7965.
Wolf D., Richter-Landsberg C., Short M. P., Cepko C., and Breakefield X. O. (1988) Retrovirus mediated transfer of beta-nerve growth factor into mouse pituitary line AcT-20. Mol. Biol. Med. 5, 43–59.
Aloe L., Cozzari C., Calissano P., and Levi-Montalcini R. (1981) Somatic and behavioral postnatal effects of fetal injections of nerve growth factor antibodies in the rat. Nature 291, 413–415.
Johnson E. M. Jr., Osborne P. A., Rydel R. E., Schmidt R. E., and Pearson J. (1983) Characterization of the effects of autoimmune nerve growth factor deprivation in the developing guinea pig. Neuroscience 8, 631–642.
Johnson E. M., Gorin P. D., Brandeis L. D., and Pearson J. (1980) Dorsal root ganglion neurons are destroyed by exposure in utero to maternal antibody to nerve growth factor. Science 210, 916–918.
Yip H. K., Rich K. M., Lampe P. A., and Johnson E. M. Jr. (1984) The effects of nerve growth factor and its antiserum on the postnatal development and survival after injury of sensory neurons in rat dorsal root ganglia. J. Neurosci. 4, 2986–2992.
Dicou E., Hurez D., and Nerrière V. (1993) Natural autoantibodies against nerve growth factor in autoimmune diseases. J. Neuroimmunol. 47, 159–168.
Kostiza T. and Meier J. (1996) Nerve growth factors from snake venoms: chemical properties, mode of action and biological significance. Toxicon 34, 787–806.
Burcham T. S., Sim I., Bolin L. M., and Shooter E. M. (1991) The NGF complex from the African rat Mastomys natalensis. Neurochem. Res. 16, 603–612.
Aloe L., Alleva E., Böhm A., and Levi-Montalcini R. (1986) Aggressive behavior induces release of nerve growth factor from mouse salivary gland into the bloodstream. Proc. Natl. Acad. Sci. USA 83, 6184–6187.
Maestripieri D., De Simone R., Aloe L., and Levi-Montalcini R. (1990) Social status and nerve growth factor serum levels after agonistic encounters in mice. Physiol. Behav. 47, 161–164.
Aloe L., Bracci-Laudiero L., Alleva E., Lambiase A., Micera A., Tirassa P. (1994) Emotional stress induced by parachute jumping changes blood nerve growth factor levels and the distribution of nerve growth factor receptors in lymphocytes. Proc. Natl. Acad. Sci. USA 91, 10,440–10,444.
Galli S. J. (1993) New concepts about the mast cell. N. Engl. J. Med. 328, 257–265.
Rozniecki J. J., Dimitriadou V., Lambracht-Hall M., Pang X., and Theoharides T. C. (1999) Morphological and functional demonstration of rat dura mater mast cell-neuron interactions in vitro and in vivo. Brain Res. 849, 1–15.
Johnson D. and Krenger W. (1992) Interactions of mast cells with the nervous system-recent advances. Neurochem. Res. 9, 939–951.
Florenzano F. and Bentivoglio M. (2000) Degranulation, density, and distribution of mast cells in the rat thalamus: a light and electron microscopic study in basal conditions and after intracerebroventricular administration of nerve growth factor. J. Comp. Neurol. 424, 651–669.
Olsson Y. (1968) Mast cells in the nervous system. Int. Rev. Cytol. 24, 27–70.
Gordon J. R., Burd P. R., and Galli S. J. (1990) Mast cells as a source of multifunctional cytokines. Immunol. Today 11, 458–464.
Purcell W. M. and Atterwill C. K. (1995) Mast cells in neuroimmune function: neurotoxicological and neuropharmacological perspectives. Neurochem. Res. 20, 521–532.
Silver R., Silverman A.-J., Vitkovic L., and Lederhendler I. I. (1996) Mast cells in the brain: evidence and functional significance. Trends Neurosci. 19, 25–31.
Hermes B., Welker P., Feldmann-Böddeker I., Krüger-Krasagakis S., Hartmann K., Zuberbier T, and Henz B. M. (2001) Expression of mast cell growth modulating and chemotactic factors and their receptors in human cutaneous scars. J. Invest. Dermatol. 116, 387–393.
Tuveri M. A., Passiu G., Mathieu A., and Aloe L. (1993) Nerve growth factor and mast cell distribution in the skin of patients with systemic sclerosis. Clin. Exp. Rheumatol. 11, 319–322.
Aloe L., Tuveri M. A., and Levi-Montalcini R. (1992) Nerve growth factor and distribution of mast cells in the synovium of adult rats. Clin. Exp. Rheumatol. 10, 203–204.
Sanico A. M., Stanisz A. M., Gleeson T. D., Bora S., Proud D., Bienenstock J., et al. (2000) Nerve growth factor expression and release in allergic inflammatory disease of the upper airways. Am. J. Respir. Crit. Care Med. 161, 1631–1635.
Bonini S., Lambiase A., Bonini S., Angelucci F., Magrini L., Manni L., and Aloe L. (1996) Circulating nerve growth factor levels are increased in humans with allergic diseases and asthma. Proc. Natl. Acad. Sci. USA 93, 10955–10960.
Braun A., Lommatzsch M., and Renz H. (2000) The role of neurotrophins in allergic bronchial asthma. Clin. Exp. Allergy 30, 178–186.
Kinkelin I., Mötzing S., Koltzenburg, and Bröcker E.-B. (2000) Increase in NGF content and nerve fiber sprouting in human allergic contact eczema. Cell Tissue Res. 302, 31–37.
di Mola F. F., Friess H., Zhu Z. W., Koliopanos A., Bley T., Di Sebastiano P., et al. (2000) Nerve growth factor and Trk high affinity receptor (TrkA) gene expression in inflammatory bowel disease. Gut 46, 670–678.
Kobayashi H., Yamataka A., Fujimoto T., Lane G. J., and Miyano T. (1999) Mast cells and gut nerve development: implications for Hirschsprung’s disease and intestinal neuronal dysplasia. J. Pediatr. Surg. 34, 543–548.
Garaci E., Caroleo M. C., Aloe L., Aquaro S., Piacentini M., Costa N., et al. (1999) Nerve growth factor is an autocrine factor essential for the survival of macrophages infected with HIV. Proc. Natl. Acad. Sci. USA 96, 14013–14018.
Simone M. D., De Santis S., Vigneti E., Papa G., Amadori S., and Aloe L. (1999) Nerve growth factor: a survey of activity on immune and hematopoietic cells. Hematol. Oncol. 17, 1–10.
Xiang Z. and Nilsson G. (2000) IgE receptormediated release of nerve growth factor by mast cells. Clin. Exp. Allergy 30, 1379–1386.
Yoshida K. and Gage F. H. (1992) Cooperative regulation of nerve growth factor synthesis and secretion in fibroblasts and astrocytes by fibroblast growth factor and other cytokines. Brain Res. 569, 14–25.
Weskamp G. and Otten U. (1987) An enzymelinked immunoassay for nerve growth factor (NGF): a tool for studying regulatory mechanisms involved in NGF production in brain and peripheral tissues. J. Neurochem. 48, 1779–1786.
Stead R. H., Kosecka-Janiszewska U., Oestreicher A. B., Dixon M. F., and Bienenstock J. (1991) Remodelling of B-50 (GAP-43)- and NSE-immunoreactive mucosal nerves in the intestines of rats with Nippostrongylus brasiliensis. J. Neurosci. 11, 3809–3821.
Blennerhasset M. G., Tomioka M., and Bienenstock J. (1991) Formation of contacts between mast cells and sympathetic neurons in vitro. Cell Tissue Res. 265, 121–128.
Waksman B. H. (1988) Autoimmunity in demyelinating diseases. Ann. NY Acad. Sci. 540, 13–24.
Sant G. R. (1989) Interstitial cystitis: pathophysiology, clinical evaluation and treatment. Urol. Ann. 3, 172–179.
Theoharides T. C. (1990) Mast cells: the immune gate to the brain Life Sci. 46, 607–617.
Skaper S. D., Facci L., Romanello S., and Leon A. (1996) Mast cell activation causes delayed neurodegeneration in mixed hippocampal cultures via the nitric oxide pathway. J. Neurochem. 66, 1157–1166.
Johnson D., Seeldrayers P. A., and Weiner H. L. (1988) The role of mast cells in demyelination. I. Myelin proteins are degraded by mast cell proteases and myelin basic protein and P2 can stimulate mast cell degranulation. Brain Res. 444, 195–198.
Theoharides T. C., Baloyannis S. J., and Manolidis L. S. (1991) Activated rat peritoneal mast cells can cause syngeneic brain demyelination in vitro. Int. J. Immunopath. Pharmacol. 4, 137–144.
Lambracht-Hall M., Dimitriadou V., and Theoharides T. C. (1990) Migration of mast cells in the developing rat brain. Dev. Brain Res. 56, 151–159.
Lambracht-Hall M., Konstantinidou A. D., and Theoharides T. C. (1990) Serotonin release from rat brain mast cells in vitro. Neuroscience 30, 199–207.
Theoharides T. C., Dimitriadou V., Letourneau R., Rozniecki J. J., Vliagoftis H., and Boucher W. (1993) Synergistic action of estradiol and myelin basic protein on mast cell secretion and brain myelin changes resembling early stages of demyelination. Neuroscience 57, 861–871.
McGeer P. L. and McGeer E. G. (1995) The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res. Rev. 21, 195–218.
Hauser S. IL., Bhan A. K., Gilles F., Kemp M., Kerr C., and Weiner H. L. (1986) Immunohistochemical analysis of the cellular infiltrate in multiple sclerosis lesions. Ann. Neurol. 19, 578–587.
Prineas J. W. and Wright R. G. (1978) Macrophages, lymphocytes, and plasma cells in the perivascular compartment in chronic multiple sclerosis. Lab. Invest. 38, 409–421.
Sobel R. A., Blanchette B. W., Bhan A. K., and Colvin R. B. (1984) The immunopathology of experimental allergic encephalomyelitis: quantitative analysis of inflammatory cells in situ. J. Immunol. 132, 2392–2401.
Olsson Y. (1974) Mast cells in plaques of multiple sclerosis. Acta Neurol. Scand. 50, 611–618.
Toms R., Weiner H. L., and Johnson D. (1990) Indentification of IgE-positive cells and mast cells in frozen sections of multiple sclerosis brains. J. Neuroimmunol. 30, 169–177.
Brosnan C. F., Lyman W. D., Tansey F. A., and Carter T. H. (1985) Quantitation of mast cells in experimental allergic neuritis. J. Neuropath. Exp. Neurol. 44, 196–203.
Askenase P. W. and Van Loveren H. (1983) Delayed-type hypersensitivity activation of mast cells by antigen-specific T-cell factors initiates the cascade of cellular interactions. Immunol. Today 4, 259–264.
Kaplan A. P., Reddigari S., Baeza M., and Kuna P. (1991) Histamine releasing factors and cytokine-dependent activation of basophils and mast cells. Adv. Immunol. 50, 237–260.
Frandji P., Oskeritzian C., Cacaraci F., Lapeyre J., Peronet R., David J. G., and Mecheri S. (1993) Antigen-dependent stimulation by bone marrow-derived mast cells of MHC class II-restricted T cell hybridoma. J. Immunol. 151, 6318–6328.
Bracci-Laudiero L., Aloe L., Levi-Montalcini R., Buttinelli C., Schilter D., Gillessen S., and Otten U. (1992) Multiple sclerosis patients express increased levels of beta-nerve growth factor in cerebrospinal fluid. Neurosci. Lett. 147, 9–12.
Mican J. M. and Metcalfe D. D. (1990) Athritis and mast cell activation. J. Allergy Appl. Immunol. 86, 677–683.
Aloe L., Tuveri M. A., Carcassi U., and Levi-Montalcini R. (1992) Nerve growth factor in the synovial fluid of patients with chronic arthritis. Arthritis Rheum. 35, 351–355.
Falcini F., Matucci Cerinic M., Lombardi A., Generini S., Pignine A., Tirassa P., et al. (1996) Increased circulating nerve growth factor is directly correlated with disease activity in juvenile chronic arthritis. Ann. Rheum. Dis. 55, 745–748.
Aloe L., Tuveri M. A., and Levi-Montalcini R. (1992) Studies on carrageenan-induced arthritis in adut rats: presence of nerve growth factor and role of sympathetic innervation. Rheumatol. Int. 12, 213–216.
Aloe L., Probert L., Kollias G., Micera A., and Tirassa P. (1995) Effect of NGF antibodies on mast cell distribution, histamine and substance P levels in the knee joint of TNF-arthritic transgenic mice. Rheumatol. Int. 14, 249–252.
Bracci-Laudiero L., Aloe L., Levi-Montalcini R., Galeazzi M., Schilter J. L., and Otten U. (1993) Increased levels of NGF in sera of systemic lupus erythematosus patients. NeuroReport 4, 563–565.
Bracci-Laudiero L., Lundeberg T., Stenfors C., Theodorsson E., Tirassa P., and Aloe L. (1996) Modification of lymphoid and brain nerve growth factor levels in systemic lupus erythematosus mice. Neurosci. Lett. 204, 13–16.
Kurosawa M., Inamura H., Amano H., Kanbe N., Nagata H., Nagai H., et al. (1999) Nerve growth factor release with mast-cell-derived mediators in a patient with systemic mastocytosis after middle-wave ultraviolet irradiation. Allergy 54, 994–998.
Treede R. D., Meyer R. A., Raja S. N., and Campbell J. N. (1992) Peripheral and central mechanisms of cutaneous hyperalgesia. Prog. Neurobiol. 38, 397–421.
Donnerer J., Schuligoi R., and Stein C. (1992) Increased content and transport of substance P and calcitonin gene-related peptide in sensory nerves innervating inflamed tissue: evidence for a regulatory function of nerve growth factor in vivo. Neuroscience 49, 693–698.
Woolf C. J., Safieh-Garabedian B., Ma Q. P., Crilly P., and Winter J. (1994) Nerve growth factor contributes to the generation of inflammatory sensory hypersensibility. Neuroscience 62, 327–331.
Woolf C. J., Allchorne A., Safieh-Garabedian B., and Poole S. (1997) Cytokines, nerve growth factor and inflammatory hyperalgesia: the contribution of tumour necrosis factor alpha. Br. J. Pharmacol. 121, 417–424.
Lewin G. R. and Mendell L. M. (1993) Nerve growth factor and nociception. Trends Neurosci. 16, 353–359.
Petty B. G., Cornblath D. R., Adornato B. T., Chaudhry V., Flexner C., Wachsman M., et al. (1994) The effect of systematically administered recombinant human nerve growth factor in healthy human subjects. (1994) Ann. Neurol. 36, 244–246.
Bennett G., al-Rashad S., Hoult J. R., and Brain S. D. (1998) Nerve growth factor induced hyperalgesia in the rat hind paw is dependent on circulating neutrophils. Pain 77, 315–322.
Andreev N. Yu, Dimitrieva N., Koltzenburg M., and McMahon S. B. (1995) Peripheral administration of nerve growth factor produces a thermal hyperalgesia that requires the presence of sympathetic post-ganglionic neurones. Pain 63, 109–115.
Bergmann I., Reiter R., Toyka K. V., and Koltzenburg M. (1998) Nerve growth factor evokes hyperalgesia in mice lacking the lowaffinity neurotrophin receptor p75. Neurosci. Lett. 255, 87–90.
Davis B. M., Lewin G. R., Mendell L. M., Jones M. E., and Albers K. M. (1993) Altered expression of nerve growth factor in the skin of transgenic mice leads to changes in response to mechanical stimuli. Neuroscience 56, 789–792.
Stucky C. L., Koltzenburg M., Schneider M., Engle M. G., Albers K. M., and Davis B. M. (1999) Overexpression of nerve growth factor in skin selectively affects the survival and functional properties of nociceptors. J. Neurosci. 19, 8509–8516.
McMahon S. B., Bennett D. L., Priestley J. V., and Shelton D. L. (1995) The biological effects of endogenous nerve growth factor on adult sensory neurons revealed by a trkA-IgG fusion molecule. Nat. Med. 1, 774–780.
Koltzenburg M., Bennett D. L., Shelton D. L., and McMahon S. B. (1999) Neutralization of endogenous NGF prevents the sensitization of nociceptors supplying inflamed skin. Eur. J. Neurosci. 11, 1698–1704.
Woolf C. J., Ma Q. P., Allchorne A., and Poole S. (1996) Peripheral cell types contributing to the hyperalgesic action nerve growth factor in inflamation. J. Neurosci. 16, 2716–2723.
Michael G. J., Averill S., Nitkunan A., Rattray M., Bennett D. L., Yan Q., and Priestley J. V. (1997) Nerve growth factor treatment increases brain-derived neurotrophic factor selectively in TrkA-expressing dorsal root ganglion cells and in their central terminations within the spinal cord. J. Neurosci. 17, 8476–8490.
Shu X. Q., Llinas A., and Mendell L. M. (1999) Effects of TrkB and trkC neurotrophin receptor agonists on thermal nociception: a behavioral and electrophysiological study. Pain 80, 463–470.
Carroll P., Lewin G. R., Koltzenburg M., Toyka K. V., and Thoenen H. (1998) A role for BDNF in mechanosensation. Nat. Neurosci. 1, 42–46.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Skaper, S.D. Nerve growth factor. Mol Neurobiol 24, 183–199 (2001). https://doi.org/10.1385/MN:24:1-3:183
Issue Date:
DOI: https://doi.org/10.1385/MN:24:1-3:183